1. The above results were approved by the Board of Directors at its meeting held on November 16, 2009.<BR><BR>2. The Company operated in one segment only - Pharmaceuticals.<BR><BR>3. In the previous year, in terms of its shareholders resolution dated November 08, 2007 the Company has issued 54,89,536 equity shares of Rs 10/- each to M/s. Ranbaxy Laboratories Ltd at a premium of Rs 150/- per share on preferential allotment basis on November 23, 2007. Out of the proceeds of Rs 8783.25 lacs from the aforesaid issue, the Company utilised the funds for repayment of secured and unsecured loans, to meet Product development expenditure and the working capital needs of the Company etc., Balance unutilised amount of Rs 3121.57 lacs has been invested in Fixed Deposits with Banks.<BR><BR>4. The public shareholding includes only general public. Ranbaxy Laboratories Ltd&amp;acute;s Shareholding in the Company, constituting 46.85% has not been included in the results, as opinion regarding status of shareholders is awaited.<BR><BR>5. Figures have been regrouped / reclassified and recast wherever necessary.<BR><BR>Dr Jayaram Chigurupati<BR>Managing Director